RxDoctor Payments Data

Shawna Sapaugh, NP

Nurse Practitioner · Sedalia, MONPI 1932764529

Payments from drug & device makers

$3,181in general payments, 2019–2025

Across 161 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Sanofi$526
  • Boehringer Ingelheim$341
  • Grifols USA, LLC$156
  • GSK$134
  • Mylan Specialty L.p.$110
  • plus $734 from 15 others

What the payments were for

  • Food & beverage$3,08497%
  • Education$973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,181 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$81,354
Medicare patients
259
Services billed
1,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HetliozTasimelteon17$409,704
OzempicSemaglutide112$124,314
MounjaroTirzepatide22$28,430
XareltoRivaroxaban27$16,810
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$13,955
JanuviaSitagliptin Phosphate17$13,603
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$5,610
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,545
Pantoprazole Sodium122$1,946
Diltiazem 24hr Er (Cd)Diltiazem Hcl68$1,938
Ventolin HfaAlbuterol Sulfate31$1,728
Gabapentin77$1,656
Albuterol Sulfate HfaAlbuterol Sulfate57$1,440
Levothyroxine Sodium174$1,395
Trimethoprim11$1,387

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$65$124,314112 claims
Lilly USA, LLCMounjaro$19$28,43022 claims
AstraZenecaBreztri Aerosphere$1,181$13,95525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Sedalia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →